• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期和复发性直肠癌行盆腔廓清术后结局的改变。

Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.

出版信息

BJS Open. 2019 Mar 6;3(4):516-520. doi: 10.1002/bjs5.50153. eCollection 2019 Aug.

DOI:10.1002/bjs5.50153
PMID:31388644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6677093/
Abstract

BACKGROUND

Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is technically challenging but increasingly performed in specialist centres. The aim of this study was to compare outcomes of exenteration over time.

METHODS

This was a multicentre retrospective study of patients who underwent exenteration for LARC and LRRC between 2004 and 2015. Surgical outcomes, including rate of bone resection, flap reconstruction, margin status and transfusion rates, were examined. Outcomes between higher- and lower-volume centres were also evaluated.

RESULTS

Some 2472 patients underwent pelvic exenteration for LARC and LRRC across 26 institutions. For LARC, rates of bone resection or flap reconstruction increased from 2004 to 2015, from 3·5 to 12·8 per cent, and from 12·0 to 29·4 per cent respectively. Fewer units of intraoperative blood were transfused over this interval (median 4 to 2 units;  = 0·040). Subgroup analysis showed that bone resection and flap reconstruction rates increased in lower- and higher-volume centres. R0 resection rates significantly increased in low-volume centres but not in high-volume centres over time (low-volume: from 62·5 to 80·0 per cent,  = 0·001; high-volume: from 83·5 to 88·4 per cent,  = 0·660). For LRRC, no significant trends over time were observed for bone resection or flap reconstruction rates. The median number of units of intraoperative blood transfused decreased from 5 to 2·5 units ( < 0·001). R0 resection rates did not increase in either low-volume (from 51·7 to 60·4 per cent;  = 0·610) or higher-volume (from 48·6 to 65·5 per cent;  = 0·100) centres. No significant differences in length of hospital stay, 30-day complication, reintervention or mortality rates were observed over time.

CONCLUSION

Radical resection, bone resection and flap reconstruction rates were performed more frequently over time, while transfusion requirements decreased.

摘要

背景

盆腔切除术用于局部晚期直肠癌(LARC)和局部复发性直肠癌(LRRC)具有一定的技术挑战性,但在专业中心的应用日益增加。本研究旨在比较随时间推移的切除术结果。

方法

这是一项对 2004 年至 2015 年间在 26 家机构接受 LARC 和 LRRC 切除术的患者进行的多中心回顾性研究。评估了手术结果,包括骨切除、皮瓣重建的比例、切缘状态和输血率。还评估了高容量和低容量中心之间的结果。

结果

共有 2472 例 LARC 和 LRRC 患者在 26 家机构接受了盆腔切除术。对于 LARC,骨切除或皮瓣重建的比例从 2004 年到 2015 年分别从 3.5%增加到 12.8%和从 12.0%增加到 29.4%。术中输血量在此期间减少(中位数 4 到 2 单位;=0.040)。亚组分析显示,在低容量和高容量中心中,骨切除和皮瓣重建的比例均有所增加。低容量中心的 R0 切除率随着时间的推移显著增加,但高容量中心则没有(低容量:从 62.5%增加到 80.0%,=0.001;高容量:从 83.5%增加到 88.4%,=0.660)。对于 LRRC,骨切除或皮瓣重建率没有随时间显著变化。术中输血量中位数从 5 单位减少到 2.5 单位(<0.001)。低容量(从 51.7%增加到 60.4%;=0.610)或高容量(从 48.6%增加到 65.5%;=0.100)中心的 R0 切除率均未增加。随着时间的推移,住院时间、30 天并发症、再次干预或死亡率无显著差异。

结论

根治性切除、骨切除和皮瓣重建的比例随时间的推移而增加,而输血需求减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b783/6677093/991bd688a23a/BJS5-3-516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b783/6677093/2cce7957b136/BJS5-3-516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b783/6677093/991bd688a23a/BJS5-3-516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b783/6677093/2cce7957b136/BJS5-3-516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b783/6677093/991bd688a23a/BJS5-3-516-g002.jpg

相似文献

1
Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.局部晚期和复发性直肠癌行盆腔廓清术后结局的改变。
BJS Open. 2019 Mar 6;3(4):516-520. doi: 10.1002/bjs5.50153. eCollection 2019 Aug.
2
Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.影响局部复发性直肠癌盆腔廓清术后结局的因素。
Br J Surg. 2018 May;105(6):650-657. doi: 10.1002/bjs.10734. Epub 2018 Mar 12.
3
Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.佩尔弗克斯协作组的当代研究结果:局部晚期和复发性直肠癌手术结果的改善。
Colorectal Dis. 2024 May;26(5):926-931. doi: 10.1111/codi.16948. Epub 2024 Apr 2.
4
Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.基于人群的研究:局部复发性直肠癌患者行与不行肿瘤切除术的手术治疗。
Br J Surg. 2019 May;106(6):790-798. doi: 10.1002/bjs.11098. Epub 2019 Feb 18.
5
Impact of flap reconstruction on perineal wound complications following ablative surgery for advanced and recurrent rectal cancers.皮瓣重建对晚期复发性直肠癌根治性手术后会阴伤口并发症的影响。
Ann Surg Oncol. 2014 Jun;21(6):2068-73. doi: 10.1245/s10434-014-3529-5. Epub 2014 Feb 13.
6
Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.营养状况和身体成分对局部晚期和局部复发性直肠癌盆腔廓清术后手术结局的影响。
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab096.
7
Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.系统评价盆腔廓清术治疗原发性和复发性局部晚期直肠癌的疗效。
Tech Coloproctol. 2018 Nov;22(11):835-845. doi: 10.1007/s10151-018-1883-1. Epub 2018 Dec 1.
8
Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.老年局部晚期和局部复发性直肠癌的全盆腔清扫术。
Eur J Surg Oncol. 2018 Oct;44(10):1548-1554. doi: 10.1016/j.ejso.2018.06.033. Epub 2018 Jul 20.
9
A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.基于前瞻性数据库的原发性晚期和局部复发性直肠癌全盆腔清扫术 10 年经验。
Colorectal Dis. 2012 Sep;14(9):1076-83. doi: 10.1111/j.1463-1318.2011.02893.x.
10
Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.局部晚期原发性直肠癌盆腔廓清术后的手术和生存结果:来自国际合作的结果。
Ann Surg. 2019 Feb;269(2):315-321. doi: 10.1097/SLA.0000000000002528.

引用本文的文献

1
Defining Standard Data Reporting in Pelvic Exenteration Surgery for Rectal Cancer: A PelvEx Collaborative Review of Current Data Reporting.直肠癌盆腔廓清手术中标准数据报告的定义:PelvEx协作组对当前数据报告的综述
Cancers (Basel). 2025 Aug 25;17(17):2764. doi: 10.3390/cancers17172764.
2
A Novel Treatment Strategy for Unresectable Locally Recurrent Rectal Cancer-Upfront Carbon-Ion Radiotherapy Followed by Surgical Resection of the Irradiated Intestines.一种针对不可切除的局部复发性直肠癌的新型治疗策略——先行碳离子放疗,随后对受照射肠道进行手术切除。
Cancers (Basel). 2025 Jul 3;17(13):2230. doi: 10.3390/cancers17132230.
3

本文引用的文献

1
Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.这段距离值得吗?前往高容量中心就医的直肠癌患者预后更佳。
Dis Colon Rectum. 2017 Dec;60(12):1250-1259. doi: 10.1097/DCR.0000000000000924.
2
The Surgeon Volume-outcome Relationship: Not Yet Ready for Policy.外科医生手术量-效果关系:尚未准备好用于政策制定。
Ann Surg. 2018 May;267(5):863-867. doi: 10.1097/SLA.0000000000002334.
3
No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.
R0 Resection Rates in Minimally Invasive Versus Open Pelvic Exenteration for Colorectal Malignancies: A Systematic Review and Meta-Analysis.
微创与开放盆腔脏器清除术治疗结直肠癌的R0切除率:一项系统评价和荟萃分析
J Surg Oncol. 2025 Jul;132(1):155-167. doi: 10.1002/jso.28149. Epub 2025 May 21.
4
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology.ELECTRA试验:低容量高复杂性外科肿瘤学双盲、随机、对照临床试验开发与实施中的当代挑战应对方法
Cancers (Basel). 2025 Jan 21;17(3):341. doi: 10.3390/cancers17030341.
5
Advances in beyond total mesorectal excision surgery: Behind the scenes.全直肠系膜切除术后手术进展:幕后故事
World J Gastrointest Surg. 2024 Nov 27;16(11):3381-3384. doi: 10.4240/wjgs.v16.i11.3381.
6
Ten-year survival and pattern of recurrence in patients with locally recurrent rectal or sigmoid cancer undergoing resection.接受手术切除的局部复发性直肠癌或乙状结肠癌患者的十年生存率及复发模式
Colorectal Dis. 2024 Dec 5;27(1). doi: 10.1111/codi.17226.
7
Open versus robotic-assisted techniques for multivisceral pelvic resections of locally advanced or recurrent colorectal and anal cancers: short-term outcomes from a single centre.开腹与机器人辅助技术在局部晚期或复发性结直肠和肛门癌的盆腔多脏器切除中的应用:单中心的短期结果。
Tech Coloproctol. 2024 Nov 19;28(1):161. doi: 10.1007/s10151-024-03044-9.
8
Pelvic Exenteration in Advanced, Recurrent or Synchronous Cancers-Last Resort or Therapeutic Option?晚期、复发性或同时性癌症的盆腔脏器切除术——是无奈之举还是治疗选择?
Diagnostics (Basel). 2024 Aug 6;14(16):1707. doi: 10.3390/diagnostics14161707.
9
Imaging in pelvic exenteration-a multidisciplinary practice guide from the ESGAR-SAR-ESUR-PelvEx collaborative group.盆腔脏器清除术的影像学——来自ESGAR-SAR-ESUR-PelvEx协作组的多学科实践指南
Eur Radiol. 2025 May;35(5):2681-2691. doi: 10.1007/s00330-024-10940-z. Epub 2024 Aug 25.
10
Management of patients with locally recurrent rectal cancer with a previous history of distant metastases: retrospective cohort study.既往有远处转移史的局部复发性直肠癌患者的管理:回顾性队列研究。
BJS Open. 2024 May 8;8(3). doi: 10.1093/bjsopen/zrae061.
荷兰结直肠癌患者的医院治疗量与总生存率之间无差异。
Dis Colon Rectum. 2016 Oct;59(10):943-52. doi: 10.1097/DCR.0000000000000660.
4
Clinical Effect of Surgical Volume.手术量的临床效果。
N Engl J Med. 2016 Apr 7;374(14):1380-2. doi: 10.1056/NEJMclde1513948.
5
High volume improves outcomes: The argument for centralization of rectal cancer surgery.高手术量可改善治疗效果:直肠癌手术集中化的论据。
Surgery. 2016 Mar;159(3):736-48. doi: 10.1016/j.surg.2015.09.021. Epub 2015 Nov 11.
6
Association of surgeon volume and hospital volume with the outcome of patients receiving definitive surgery for colorectal cancer: A nationwide population-based study.外科医生手术量和医院手术量与接受结直肠癌确定性手术患者结局的关联:一项全国范围内基于人群的研究。
Cancer. 2015 Aug 15;121(16):2782-90. doi: 10.1002/cncr.29356. Epub 2015 Apr 17.
7
The Influence of Hospital Volume on Circumferential Resection Margin Involvement: Results of the Dutch Surgical Colorectal Audit.医院手术量对环周切缘受累情况的影响:荷兰结直肠外科审计结果
Ann Surg. 2016 Apr;263(4):745-50. doi: 10.1097/SLA.0000000000001009.
8
Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009.1989 年至 2009 年荷兰医院容量对食管和胃癌手术后术后死亡率和生存率的影响。
Eur J Cancer. 2012 May;48(7):1004-13. doi: 10.1016/j.ejca.2012.02.064. Epub 2012 Mar 27.
9
Breast cancer surgery: do all patients want to go to high-volume hospitals?乳腺癌手术:所有患者都想去大型医院吗?
Surgery. 2008 Jun;143(6):699-705. doi: 10.1016/j.surg.2008.03.013. Epub 2008 May 9.
10
Hospital volume and late survival after cancer surgery.癌症手术后的医院手术量与远期生存率
Ann Surg. 2007 May;245(5):777-83. doi: 10.1097/01.sla.0000252402.33814.dd.